Literature DB >> 21454535

Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

Hélène Tran1, Nathalie Gourrier, Camille Lemercier-Neuillet, Claire-Marie Dhaenens, Audrey Vautrin, Francisco José Fernandez-Gomez, Ludovic Arandel, Céline Carpentier, Hélène Obriot, Sabiha Eddarkaoui, Lucie Delattre, Edwige Van Brussels, Ian Holt, Glenn E Morris, Bernard Sablonnière, Luc Buée, Nicolas Charlet-Berguerand, Susanna Schraen-Maschke, Denis Furling, Isabelle Behm-Ansmant, Christiane Branlant, Marie-Laure Caillet-Boudin, Nicolas Sergeant.   

Abstract

Muscleblind-like-1 (MBNL1) is a splicing regulatory factor controlling the fetal-to-adult alternative splicing transitions during vertebrate muscle development. Its capture by nuclear CUG expansions is one major cause for type 1 myotonic dystrophy (DM1). Alternative splicing produces MBNL1 isoforms that differ by the presence or absence of the exonic regions 3, 5, and 7. To understand better their respective roles and the consequences of the deregulation of their expression in DM1, here we studied the respective roles of MBNL1 alternative and constitutive exons. By combining genetics, molecular and cellular approaches, we found that (i) the exon 5 and 6 regions are both needed to control the nuclear localization of MBNL1; (ii) the exon 3 region strongly enhances the affinity of MBNL1 for its pre-mRNA target sites; (iii) the exon 3 and 6 regions are both required for the splicing regulatory activity, and this function is not enhanced by an exclusive nuclear localization of MBNL1; and finally (iv) the exon 7 region enhances MBNL1-MBNL1 dimerization properties. Consequently, the abnormally high inclusion of the exon 5 and 7 regions in DM1 is expected to enhance the potential of MBNL1 of being sequestered with nuclear CUG expansions, which provides new insight into DM1 pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454535      PMCID: PMC3091249          DOI: 10.1074/jbc.M110.194928

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA.

Authors:  A Kosaki; J Nelson; N J Webster
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

2.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

3.  Localization of trinucleotide repeat sequences in myotonic dystrophy cells using a single fluorochrome-labeled PNA probe.

Authors:  K L Taneja
Journal:  Biotechniques       Date:  1998-03       Impact factor: 1.993

4.  The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2.

Authors:  R Artero; A Prokop; N Paricio; G Begemann; I Pueyo; M Mlodzik; M Perez-Alonso; M K Baylies
Journal:  Dev Biol       Date:  1998-03-15       Impact factor: 3.582

5.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

6.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

7.  Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.

Authors:  Yoshihiro Kino; Daisuke Mori; Yoko Oma; Yuya Takeshita; Noboru Sasagawa; Shoichi Ishiura
Journal:  Hum Mol Genet       Date:  2004-01-13       Impact factor: 6.150

8.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

9.  Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains.

Authors:  F Edom; V Mouly; J P Barbet; M Y Fiszman; G S Butler-Browne
Journal:  Dev Biol       Date:  1994-07       Impact factor: 3.582

10.  muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins.

Authors:  G Begemann; N Paricio; R Artero; I Kiss; M Pérez-Alonso; M Mlodzik
Journal:  Development       Date:  1997-11       Impact factor: 6.868

View more
  32 in total

1.  Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.

Authors:  Devika P Gates; Leslie A Coonrod; J Andrew Berglund
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

2.  Mechanistic determinants of MBNL activity.

Authors:  Łukasz J Sznajder; Michał Michalak; Katarzyna Taylor; Piotr Cywoniuk; Michał Kabza; Agnieszka Wojtkowiak-Szlachcic; Magdalena Matłoka; Patryk Konieczny; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2016-10-12       Impact factor: 16.971

3.  Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats.

Authors:  Ludovic Arandel; Magdalena Matloka; Arnaud F Klein; Frédérique Rau; Alain Sureau; Michel Ney; Aurélien Cordier; Maria Kondili; Micaela Polay-Espinoza; Naira Naouar; Arnaud Ferry; Mégane Lemaitre; Séverine Begard; Morvane Colin; Chloé Lamarre; Hélène Tran; Luc Buée; Joëlle Marie; Nicolas Sergeant; Denis Furling
Journal:  Nat Biomed Eng       Date:  2022-02-10       Impact factor: 25.671

4.  Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise.

Authors:  Christopher M Chamberlain; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2012-07-30       Impact factor: 6.150

5.  A fly model for the CCUG-repeat expansion of myotonic dystrophy type 2 reveals a novel interaction with MBNL1.

Authors:  Zhenming Yu; Lindsey D Goodman; Shin-Yi Shieh; Michelle Min; Xiuyin Teng; Yongqing Zhu; Nancy M Bonini
Journal:  Hum Mol Genet       Date:  2014-10-09       Impact factor: 6.150

Review 6.  RNA-protein interactions in unstable microsatellite diseases.

Authors:  Apoorva Mohan; Marianne Goodwin; Maurice S Swanson
Journal:  Brain Res       Date:  2014-04-04       Impact factor: 3.252

7.  New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.

Authors:  François-Xavier Laurent; Alain Sureau; Arnaud F Klein; François Trouslard; Erwan Gasnier; Denis Furling; Joëlle Marie
Journal:  Nucleic Acids Res       Date:  2011-12-09       Impact factor: 16.971

8.  MBNL1 and PTB cooperate to repress splicing of Tpm1 exon 3.

Authors:  Clare Gooding; Christopher Edge; Mike Lorenz; Miguel B Coelho; Mikael Winters; Clemens F Kaminski; Dmitry Cherny; Ian C Eperon; Christopher W J Smith
Journal:  Nucleic Acids Res       Date:  2013-03-19       Impact factor: 16.971

9.  MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases.

Authors:  A Botta; A Malena; E Tibaldi; L Rocchi; E Loro; E Pena; L Cenci; E Ambrosi; M C Bellocchi; M A Pagano; G Novelli; G Rossi; H L Monaco; E Gianazza; B Pantic; V Romeo; O Marin; A M Brunati; L Vergani
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

10.  Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy.

Authors:  Melissa N Hinman; Jared I Richardson; Rose A Sockol; Eliza D Aronson; Sarah J Stednitz; Katrina N Murray; J Andrew Berglund; Karen Guillemin
Journal:  Dis Model Mech       Date:  2021-06-14       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.